A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors

This publication has 31 references indexed in Scilit:

• Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
  Published by Elsevier ,2004
• Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis
  Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2004
• Issues and progress with protein kinase inhibitors for cancer treatment
  Nature Reviews Drug Discovery, 2003
• The Protein Kinase Complement of the Human Genome
  Science, 2002
• Protein kinases — the major drug targets of the twenty-first century?
  Nature Reviews Drug Discovery, 2002
• Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
  Nature Structural & Molecular Biology, 2002
• Oncogenic kinase signalling
  Nature, 2001
• Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
  Science, 2000
• Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors
  Pharmacology & Therapeutics, 1999
• Crystal structure of the tyrosine kinase domain of the human insulin receptor
  Nature, 1994